The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company presents an extensive market research report on the Enteral Nutrition Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.

Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing all necessary data for thriving in the industry. This report market research offers a comprehensive perspective, including an in-depth analysis of the present and future scenarios within the industry.

Market Sizing:
The enteral nutrition market size has grown strongly in recent years. It will grow from $11.55 billion in 2023 to $12.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to clinical need, hospital and clinical settings, surgical procedures, improved feeding tubes, increased awareness.

The enteral nutrition market size is expected to see strong growth in the next few years. It will grow to $16.8 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to patient-centric care, chronic health conditions, home-based care, personalized nutrition, rise in gastrointestinal disorders. Major trends in the forecast period include optimization of administration techniques, tube placement technologies, modular and tailored nutrition solutions, immunonutrition development, home enteral feeding kits.

Request for free sample report –
https://www.thebusinessresearchcompany.com/sample.aspx?id=11975&type=smp

Key Market Players:
Major companies operating in the enteral nutrition market report are Cardinal Health Inc., Nestle S.A., Fresenius Kabi AG, Abbott Laboratories, Medtronic Inc., Danone S.A., Becton, Dickinson and Company, Otsuka Pharmaceutical Factory, Boston Scientific Corporation, Hormel Foods Corporation, B. Braun Melsungen AG, Reckitt Benckiser Group PLC, Meiji Holdings Co. Ltd., C. R. Bard GmbH, Moog Inc., Mead Johnson Nutrition, Cook Medical, Halyard Health Inc., Avanos Medical Inc., Applied Medical, Angiplast Pvt Ltd., Kate Farms, Global Health Products Inc., Victus Inc., VYGON SAS

Market Drivers:
The increase in the prevalence of chronic disease is expected to drive the demand for enteral nutrition. Chronic or non-communicable diseases (NCDs) are long-term conditions that typically progress slowly and persist over an extended period. It includes cardiovascular diseases, diabetes, respiratory diseases, cancer, chronic kidney disease, neurological diseases, rheumatoid arthritis, and other autoimmune diseases. Enteral nutrition can be used as a supportive measure for patients who have difficulty eating or maintaining adequate nutrition due to the disease or its treatments. For instance, in 2023, according to the report published by the American Cancer Society, Inc, a US-based nationwide voluntary health organization dedicated to eliminating cancer, estimated new cases of liver cancer in females diagnosed in the United States increased from 12,660 in 2022 to 13,230 in 2023. Further, in December 2021, according to the statistics published by International Diabetes Federation, a Belgium-based, non-profit diabetes association, in 2021, 537 million adults (20-79 years) recorded living with diabetes, and 6.7 million people died of diabetes in 2021. However, by 2030, it is anticipated that 643 million people worldwide will have diabetes. Therefore, the increase in chronic disease prevalence is driving the enteral nutrition market.

Learn More About The Market Report –
https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

The enteral nutrition market covered in this report is segmented –
1) By Product Type: Standard Enteral Nutrition, Enteral Nutrition For Chronic Illness
2) By Nutrition Type: Proteins, Carbohydrates, Multi Vitamins, Antioxidants, Amino Acids, Fibers, Minerals, Other Nutritional Types
3) By Patient Type: Adults, Pediatric
4) By Application: Cancer, Critical Care, Diabetes, Gastrointestinal Diseases, Other Applications
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The report answers the following questions:
What are the primary factors propelling the market during the projected period?

In which region is the most substantial growth expected?

Which trend will take center stage in the upcoming period?

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC’s consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model – World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.